{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:53:45Z","timestamp":1790880825588,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","award":["1125825N"],"award-info":[{"award-number":["1125825N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Translational Autoimmunity"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jtauto.2025.100282","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T03:18:41Z","timestamp":1741317521000},"page":"100282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The AhR pathway is dysregulated in alopecia areata"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7484-8413","authenticated-orcid":false,"given":"Arno","family":"Belpaire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4782-634X","authenticated-orcid":false,"given":"Annelies","family":"Demeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3224-5260","authenticated-orcid":false,"given":"Elise","family":"Van Caelenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanja","family":"van Geel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9421-3546","authenticated-orcid":false,"given":"Reinhart","family":"Speeckaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtauto.2025.100282_bib2","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.3389\/fimmu.2019.02342","article-title":"Targeting the janus kinase family in autoimmune skin diseases","volume":"10","author":"Howell","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2025.100282_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.955035","article-title":"An overview of JAK\/STAT pathways and JAK inhibition in alopecia areata","volume":"13","author":"Lensing","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2025.100282_bib4","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2133.2006.07377.x","article-title":"Interferon\u2010\u03b3\u2010deficient mice are resistant to the development of alopecia areata","volume":"155","author":"Freyschmidt\u2010Paul","year":"2006","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jtauto.2025.100282_bib5","first-page":"212","article-title":"Serum concentrations of interferon-gamma (IFN-g) in patients with alopecia areata: correlation with clinical type and duration of the disease","volume":"64","author":"Kasumagic-Halilovic","year":"2010","journal-title":"Med. Arh."},{"key":"10.1016\/j.jtauto.2025.100282_bib6","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/exd.14155","article-title":"Hair follicle immune privilege and its collapse in alopecia areata","volume":"29","author":"Bertolini","year":"2020","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jtauto.2025.100282_bib7","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1684\/ejd.2022.4315","article-title":"Alopecia areata as an immune-related adverse event associated with response to immune checkpoint inhibitors","volume":"32","author":"Suzuki","year":"2022","journal-title":"Eur J Dermatol EJD"},{"key":"10.1016\/j.jtauto.2025.100282_bib8","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.3390\/cells10123397","article-title":"The role of serum Th1, Th2, and Th17 cytokines in patients with alopecia areata: clinical implications","volume":"10","author":"Wa\u015bkiel-Burnat","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jtauto.2025.100282_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2024.114259","article-title":"Changes and significance of Th1\/Th2 and Treg\/Th17 cells and their cytokines in patients with alopecia areata","volume":"442","author":"Yang","year":"2024","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jtauto.2025.100282_bib10","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/j.jid.2024.02.004","article-title":"Decreased CD19+CD24hiCD38hi regulatory B cells in alopecia areata","volume":"144","author":"Lee","year":"2024","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jtauto.2025.100282_bib11","doi-asserted-by":"crossref","first-page":"465","DOI":"10.4103\/idoj.idoj_452_22","article-title":"Which is the ideal JAK inhibitor for alopecia areata - baricitinib, tofacitinib, ritlecitinib or ifidancitinib - revisiting the immunomechanisms of the JAK pathway","volume":"14","author":"Sardana","year":"2023","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.jtauto.2025.100282_bib12","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s40261-023-01260-z","article-title":"Safety of janus kinase inhibitors in patients with alopecia areata: a systematic review","volume":"43","author":"Papierzewska","year":"2023","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.jtauto.2025.100282_bib13","article-title":"Alopecia areata after initiation of secukinumab therapy for plaque psoriasis","volume":"15","author":"Choi","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jtauto.2025.100282_bib14","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00403-018-1853-5","article-title":"Efficacy and safety of secukinumab treatment in adults with extensive alopecia areata","volume":"310","author":"Guttman-Yassky","year":"2018","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.jtauto.2025.100282_bib15","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/all.15561","article-title":"Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata","volume":"78","author":"Renert-Yuval","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jtauto.2025.100282_bib16","first-page":"4846","article-title":"Identification of a new pathway for Th1 cell development induced by cooperative stimulation with IL-4 and TGF-\u03b2","volume":"188","author":"Tofukuji","year":"1950","journal-title":"J Immunol Baltim Md"},{"key":"10.1016\/j.jtauto.2025.100282_bib17","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1038\/s44321-024-00135-w","article-title":"The influence of AHR on immune and tissue biology","volume":"16","author":"Stockinger","year":"2024","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jtauto.2025.100282_bib18","article-title":"Kynurenine pathway of tryptophan metabolism: regulatory and functional aspects","volume":"10","author":"Badawy","year":"2017","journal-title":"Int J Tryptophan Res IJTR"},{"key":"10.1016\/j.jtauto.2025.100282_bib19","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1517\/14728222.9.4.831","article-title":"Indoleamine 2,3-dioxygenase in cancer: targeting pathological immune tolerance with small-molecule inhibitors","volume":"9","author":"Muller","year":"2005","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.jtauto.2025.100282_bib20","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ccell.2018.02.005","article-title":"Tumor-Repopulating cells induce PD-1 expression in CD8+ T cells by transferring kynurenine and AhR activation","volume":"33","author":"Liu","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jtauto.2025.100282_bib21","article-title":"The aryl hydrocarbon receptor controls ifn\u03b3-induced immune checkpoints PD-L1 and Ido via the JAK\/STAT pathway in lung adenocarcinoma","volume":"2024","author":"Snyder","year":"2024","journal-title":"BioRxiv Prepr Serv Biol"},{"key":"10.1016\/j.jtauto.2025.100282_bib23","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jaad.2016.08.042","article-title":"Salt II: a new take on the Severity of Alopecia Tool (SALT) for determining percentage scalp hair loss","volume":"75","author":"Olsen","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jtauto.2025.100282_bib24","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.it.2012.05.004","article-title":"Defining the human T helper 17 cell phenotype","volume":"33","author":"Annunziato","year":"2012","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jtauto.2025.100282_bib25","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ccell.2018.02.005","article-title":"Tumor-Repopulating cells induce PD-1 expression in CD8+ T cells by transferring kynurenine and AhR activation","volume":"33","author":"Liu","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jtauto.2025.100282_bib26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5114\/ada.2023.135617","article-title":"Aryl hydrocarbon receptor role in chronic inflammatory skin diseases: a narrative review","volume":"41","author":"Dec","year":"2024","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1016\/j.jtauto.2025.100282_bib27","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.toxlet.2023.05.007","article-title":"Aryl hydrocarbon receptor is regulated via multiple mechanisms in human keratinocytes","volume":"382","author":"Rudyak","year":"2023","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.jtauto.2025.100282_bib28","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.3390\/cells10113176","article-title":"Role of AHR ligands in skin homeostasis and cutaneous inflammation","volume":"10","author":"Fern\u00e1ndez-Gallego","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jtauto.2025.100282_bib29","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/stem.3443","article-title":"Aryl hydrocarbon receptor controls skin homeostasis, regeneration, and hair follicle cycling by adjusting epidermal stem cell function","volume":"39","author":"Rico-Leo","year":"2021","journal-title":"Stem Cells Dayt Ohio"},{"key":"10.1016\/j.jtauto.2025.100282_bib30","article-title":"Blockade of Ido-kynurenine-AhR metabolic circuitry abrogates IFN-\u03b3-induced immunologic dormancy of tumor-repopulating cells","volume":"8","author":"Liu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jtauto.2025.100282_bib31","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/exd.12350","article-title":"Increased expression of the aryl hydrocarbon receptor in patients with chronic inflammatory skin diseases","volume":"23","author":"Kim","year":"2014","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jtauto.2025.100282_bib32","first-page":"90","article-title":"Effects of kynurenine on CD3+ and macrophages in wound healing","volume":"23","author":"Salimi","year":"2015","journal-title":"Wound Repair Regen Off Publ Wound Heal Soc Eur Tissue Repair Soc"},{"key":"10.1016\/j.jtauto.2025.100282_bib33","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1016\/j.jid.2017.05.004","article-title":"Tapinarof is a natural AhR agonist that resolves skin inflammation in mice and humans","volume":"137","author":"Smith","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jtauto.2025.100282_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2023.12.013","article-title":"Tapinarof validates the aryl hydrocarbon receptor as a therapeutic target: a clinical review","volume":"154","author":"Silverberg","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jtauto.2025.100282_bib35","article-title":"AhR agonist tapinarof ameliorates lupus autoimmunity by suppressing Tfh cell differentiation via regulation of the JAK2\u2010STAT3 signaling pathway","volume":"11","author":"Zhang","year":"2023","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.jtauto.2025.100282_bib36","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.toxlet.2023.05.007","article-title":"Aryl hydrocarbon receptor is regulated via multiple mechanisms in human keratinocytes","volume":"382","author":"Rudyak","year":"2023","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.jtauto.2025.100282_bib37","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1590\/abd1806-4841.20175150","article-title":"Aryl hydrocarbon receptor overexpression in miniaturized follicles in female pattern hair loss","volume":"92","author":"Ramos","year":"2017","journal-title":"An. Bras. Dermatol."}],"container-title":["Journal of Translational Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909025000176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909025000176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T22:56:52Z","timestamp":1750892212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589909025000176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":35,"alternative-id":["S2589909025000176"],"URL":"https:\/\/doi.org\/10.1016\/j.jtauto.2025.100282","relation":{},"ISSN":["2589-9090"],"issn-type":[{"value":"2589-9090","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The AhR pathway is dysregulated in alopecia areata","name":"articletitle","label":"Article Title"},{"value":"Journal of Translational Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtauto.2025.100282","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100282"}}